4//SEC Filing
Inbar Galia 4
Accession 0001209191-23-016708
CIK 0000818686other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:08 PM ET
Size
14.0 KB
Accession
0001209191-23-016708
Insider Transaction Report
Form 4
Inbar Galia
See "Remarks"
Transactions
- Exercise/Conversion
Ordinary Shares
2023-03-04+20,107→ 40,301 total - Exercise/Conversion
Ordinary Shares
2023-03-05+5,710→ 46,011 total - Award
Restricted Share Units
2023-03-03+59,760→ 59,760 total→ Ordinary Shares (59,760 underlying) - Exercise/Conversion
Restricted Share Units
2023-03-04−20,107→ 60,321 total→ Ordinary Shares (20,107 underlying) - Exercise/Conversion
Restricted Share Units
2023-03-05−5,710→ 11,422 total→ Ordinary Shares (5,710 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027.
- [F4]Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025, and March 4, 2026.
- [F5]Restricted share units were granted on March 5, 2021, with 5,710 vested on each of March 5, 2022 and March 5, 2023, 5,710 vesting on March 5, 2024, and 5,712 vesting on March 5, 2025.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001878086
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:08 PM ET
- Size
- 14.0 KB